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Abstract
Objective: Resistance vessel remodeling is controlled by myriad of hemodynamic and neurohormonal factors. This study
characterized structural and molecular remodeling in mesenteric resistance arteries (MRAs) in diabetic (db/db) and control
(Db/db) mice.
Methods: Structural properties were assessed in isolated MRAs from 12 and 16 wk-old db/db and Db/db mice by pressure
myography. Matrix regulatory proteins were measured by Western blot analysis. Mean arterial pressure and superior
mesenteric blood flow were measured in 12 wk-old mice by telemetry and a Doppler flow nanoprobe, respectively.
Results: Blood pressure was similar between groups. Lumen diameter and medial cross-sectional area were significantly
increased in 16 wk-old db/db MRA compared to control, indicating outward hypertrophic remodeling. Moreover, wall stress
and cross-sectional compliance were significantly larger in diabetic arteries. These remodeling indices were associated with
increased expression of matrix regulatory proteins matrix metalloproteinase (MMP)-9, MMP-12, tissue inhibitors of matrix
metalloproteinase (TIMP)-1, TIMP-2, and plasminogen activator inhibitor-1 (PAI-1) in db/db arteries. Finally, superior
mesenteric artery blood flow was increased by 46% in 12 wk-old db/db mice, a finding that preceded mesenteric resistance
artery remodeling.
Conclusions: These data suggest that flow-induced hemodynamic changes may supersede the local neurohormonal and
metabolic milieu to culminate in hypertrophic outward remodeling of type 2 DM mesenteric resistance arteries.
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Introduction
Diabetes mellitus (DM) is the fifth leading cause of death in
the United States, and type 2 DM accounts for 90–95% of all
diabetic cases for which vascular complications are a leading
cause of morbidity, mortality and economic burden [1]. Chronic
hyperglycemia, coupled with insulin resistance, is a hallmark of
type 2 DM and underlies many of the observed pathophysio-
logical complications in the cardiovascular system [2,3].
Moreover, type 2 DM is associated with a cluster of risk factors
including obesity, hypercholesterolemia, hyperlipidemia and
hypertension. Together, these factors lead to increased accumu-
lation of advanced glycation end products, alterations in the
renin-angiotensin system (RAS), oxidative stress, and reduced
nitric oxide bioavailability [4,5,6] culminating in endothelial
dysfunction, altered vasoreactivity, and vessel wall remodeling
[7,8].
Although the regulation of resistance artery function has been
extensively studied within the context of type 2 DM, much less is
known about the mechanisms that dictate diabetes-associated
structural remodeling of the microvasculature. Vascular remod-
eling involves the reorganization of existing cells and extracel-
lular matrix (ECM) or changes in vascular smooth muscle cell
(VSMC) growth and migration [9], and can be characterized as
hypertrophic (increased cross-sectional area), eutrophic (no
change in cross-sectional area) or hypotrophic remodeling
(reduced cross-sectional area). These processes have been
associated with either inward remodeling (smaller lumen
diameter) or outward remodeling (increased lumen diameter)
[10]. In small resistance arteries from type 2 diabetic patients,
hypertrophic remodeling and reduced fibrosis has been reported
[11]. In contrast, hypertensive patients with pre-existing type
2 DM had predominantly eutrophic remodeling and increased
fibrosis [12].
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the remodeling process. The ECM not only dictates in part the
integrity of the vessel wall, but is also an important determinant of
vessel compliance; however, the molecular mechanisms that
dictate ECM accumulation and turnover in diabetic microvessels
have not been extensively studied. A balance between matrix
metalloproteinases (MMPs) and tissue inhibitors of matrix
metalloproteinases (TIMPs) is thought to play a central role in
vessel remodeling, and an imbalance between MMPs and TIMPs
may lead to excess ECM accumulation or degradation [13,14].
For example, diabetic nephropathy and cardiomyopathy involves
excessive ECM deposition due to a decrease in the MMP/TIMP
ratio [15,16]. The pro-fibrotic plasminogen activator inhibitor-1
(PAI-1) is increased in DM, insulin resistance, and hypertension
[17].
In addition to neurohormonal regulation of ECM and VSMC
growth, hemodynamics also dictate the pattern of microvascular
remodeling. For example, outward remodeling occurs in response
to chronic increases in blood flow in rat mesenteric resistance
arteries [18]. Thus, the pattern of vascular remodeling in diabetes
may be tissue-specific, reflecting a dynamic interaction between
hyperglycemia, hemodynamic stimuli and locally generated
angiotensin II, as well as oxidative stress and inflammation [19].
The aim of the present study was to examine mesenteric resistance
arteriole (MRA) structure in leptin-receptor deficient db/db mice,
a model of type 2 DM, insulin-resistance, hyperlipidemia and
obesity.
Materials and Methods
Ethics Statement
This study conformed with the Guide for the Care and Use of
Laboratory Animals published by the U.S. National Institutes of
Health (NIH Publication No. 85–23, revised 1996) and was
approved by the LSU Health Sciences Center Institutional Animal
Care and Use Committee (IACUC protocol number 2498,
Institutional Animal Assurance number A3094-01) and the
Nationwide Children’s Hospital Institutional Animal Care and
Use Committee (IACUC protocol number AR08-00023, Institu-
tional Animal Assurance Number A3544-01).
Animals
All experiments used 12 and 16 wk-old male type 2 DM db/db
(C57BL/KsJ-db-/db-) and control heterozygous Db/db mice
(C57BL/KsJ-db+/db2, The Jackson Laboratory, Bar Harbor,
ME, USA). By 4 wks of age db/db mice are obese, develop
hyperglycemia by 8 wks of age, overt DM by 12 wks of age, and
exhibit many common features of type 2 DM, including
hyperlipidemia, obesity and insulin resistance. Heterozygous mice
were used as control, which cannot be distinguished morpholog-
ically or physiologically from wild type mice (data not shown).
Mice were housed under a 12-hour light/dark cycle at 22uC and
60% humidity. They were allowed ad libitum access to water and
standard laboratory mouse chow.
Blood Pressure and Blood Glucose Measurements
Radiotelemetry transmitter catheters were implanted into the
right carotid arteries of 16 wk-old Db/db and db/db mice using
aseptic surgical techniques in animals anesthetized with 2%
isoflurane. A subcutaneous space was bluntly dissected in the right
flank region to house the radiotelemetry transmitter (Model
PhysioTel PA-C10; Data Sciences International, St. Paul, MN,
USA). Baseline mean arterial blood pressure was recorded for 4
weeks in conscious, freely moving mice using Dataquest A.R.T
(Data Sciences, St. Paul, MN, USA) acquisition software after the
return of diurnal cycles (10 days post surgery). Following the
acquisition of baseline blood pressure and heart rate, data were
collected for one hour at the same time each day and averaged
into 2-second bins over 7 days. Prior to the terminal vessel
experiment and 12 hours after fasting, blood glucose was
measured with an Accu-Chek II portable glucose meter (Roche,
Indianapolis, IN, USA).
Mesenteric Isolation
Db/db and db/db mice were anesthetized using ketamine
(200 mg kg
21, ip) and xylazine (10 mg kg
21, ip). Mesenteric
resistance arteries at the fourth to fifth branch of the superior
mesenteric artery were dissected and isolated from surrounding
adipose and connective tissue using a dissecting microscope and
mounted onto two glass micropipettes in a video-monitored
perfusion system as previously described [20]. The intravascular
pressure was controlled by a pressure servo control (Living Systems
Instrumentation, Burlington, VT, USA). Additional MRAs were
isolated from separate sets of Db/db and db/db mice and either
formalin fixed (10% phosphate buffered formalin) or frozen in
liquid N2 for histological or biochemical experiments, respectively.
Experimental Protocol
Isolated MRAs were bathed in a 4 mL chamber with
physiological salt solution (PSS, pH 7.4, 37uC) containing (in
mmol/L): 130 NaCl, 14.9 NaHCO3, 3.7 KCl, 1.6 CaCl2-2H2O,
1.2 KH2PO4, 1.2 MgSO4-7H2O, 11 glucose, and 10 HEPES.
Arteries were equilibrated at 50 mmHg luminal pressure under
no-flow conditions for 45 min and bathed in PSS at 37uC. Arteries
were then maximally relaxed with Ca
2+-free-PSS supplemented
with 2 mmol/L EGTA and 100 mmol/L sodium nitroprusside.
After 30 min equilibration, intraluminal pressure was recorded as
the baseline passive diameter (PD). A passive pressure-diameter
curve was generated by stepwise increases in intraluminal pressure
from 10 to 125 mmHg. Both internal diameter (Di) and wall
thickness (WT) were measured.
Mesenteric Resistant Artery Measurements
The following structural and mechanical parameters were
determined as previously described [20,21]:
Media cross-sectional area (CSA) =p (De
22Di
2)/ 4
Cross-sectional compliance (Ccs, mm
2 mmHg
21)= DAi/DP, in
which DAi is the change in internal lumen cross-sectional area
induced by a pressure change (DP).
Cross-sectional distensibility (Dcs, kPa
21) as Dcs=Ccs/Ai
Circumferential wall strain (e) = (D–D0)/ D 0, where D was the
observed lumen diameter for a given intraluminal pressure and D0
was the original diameter measured at 10 mmHg intraluminal
pressure.
Circumferential wall stress (s) = (PD)/(2WT), where P is the
intraluminal pressure and D is the lumen diameter. Pressure is
converted to dynes per cm
2 (1 mmHg=1.3343610
5 dynes/cm
2)
when stress is examined as a function of strain.
Incremental Elastic Modulus (Einc)= Ds/De, which is used
when the stress-strain curve is curvilinear rather than linear.
Vascular Morphology
Formalin fixed, paraffin-embedded, fourth to fifth order isolated
mesenteric resistance arteries from 16 wk-old mice were sectioned
(6 mm), stained with picrosirius red (PSR) for collagen and
quantified using picrosirius polarization methods [22]. The images
were digitized using Olympus MicroSuite 5. Two sections per
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collagen area percent and was normalized to medial cross sectional
area.
Western Blot Analysis
Tissue lysates from 16 wk-old mice were prepared from MRAs
in a buffer containing 0.1% Triton X-100 and (in mmol/L); 50
NaCl, 1 MgCl2, 25 HEPES (pH 7.4), 2 EGTA, 10 NaF, 0.1
Na3VO4, 10 Na-Pyrophosphate, and 0.1% deoxycholate and
protease inhibitors. Protein concentration was determined using
the bicinchoninic acid assay (Pierce, Rockford, IL, USA). Equal
amounts of protein from each sample (40–50 mg) were separated
on 10% SDS-PAGE gels. Nitrocellulose membranes were stained
with Ponceau Red to verify even transfer. Membranes were then
blocked and incubated overnight at 4uC with the following
primary antisera: anti-MMP-9, anti-TIMP-1, and anti-TIMP-2
(Millipore, formerly Chemicon, Collerica, MA, USA), anti-MMP-
12 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-PAI-1
(BD Biosciences, formerly Transduction Laboratories, San Jose,
CA, USA), anti-GAPDH (AbCam, Cambridge, MA, USA) as a
loading control and horseradish peroxidase-conjugated secondary
antisera (GE Healthcare, formerly Amersham Biosciences, Piscat-
away, NJ, USA). Blots were developed using SuperSignal reagents
(Pierce, Rockford, IL, USA) and exposed on x-ray film. Im-
munoreactive bands were quantified by densitometry using an
Alpha Innotech gel imaging system (Cell Biosciences, Santa Clara,
CA, USA), and data were normalized to GAPDH levels.
Table 1. Physiological parameters of control and diabetic
mice.
Control (Db/db) Diabetic (db/db)
Blood Glucose (mg/dL) 128610 506635***
Body Weight (g) 29.860.4 55.661***
Systolic Blood Pressure
(mmHg)
11662.7 11461.7
Unpaired t-test: Db/db vs db/db,
***p,0.001, means 6 SEM. Blood glucose and body weight, n=10 for each
group. Blood pressure, n=6 for each group.
doi:10.1371/journal.pone.0023337.t001
Figure 1. Lumen diameter (77.9±5.6 vs 120.6±5.5 mm at 75 mmHg, p,0.001), external diameter (110.4±6.4 vs 153.1±5.2 mma t
75 mmHg, p,0.001) and media cross-sectional area (4860.4±464.7 vs 6972.4±272.1 mm
2 at 75 mmHg, p,0.001) were increased in
16 wk-old db/db MRAs while wall:lumen ratio (21.3±1.2 vs 13.7±0.8 at 75 mmHg, p,0.01) was decreased when compared to Db/
db mice under physiological pressures of 50, 75 and 100 mmHg: a. Lumen diameter, b. external diameter, c. cross-sectional area, d.
wall:lumen ratio. Two-way ANOVA: Db/db vs db/db, * p,0.05 ** p,0.01 *** p,0.001, means 6 SEM; n=8 for each group.
doi:10.1371/journal.pone.0023337.g001
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Direct hemodynamic measures of superior mesenteric blood
flow were performed in 12 wk-old male Db/db (n=5) and db/db
(n=6) mice. Mice were maintained on isoflurane anesthesia
(2.25%) at a body temperature of 37uC. The superior mesenteric
artery was carefully isolated and a Doppler flow nanoprobe
(Model 0.7PSB, Transonic Systems, Inc., Ithaca, NY) connected to
a TS420 perivascular flowmeter (Transonic Systems, Inc., Ithaca,
NY, USA) was gently placed around the artery. A 3-minute
average of mesenteric blood flow was recorded and analyzed after
a 25-minute equilibration period using LabScribe 2 data
acquisition and analysis software (iWORX Systems, Inc., Dover,
NH, USA).
Data Analysis
Unpaired Student’s t-test or two-way repeated measures
ANOVA was used when appropriate. Data are presented as
mean 6 SEM, with p,0.05 representing significance.
Results
Blood Pressure and Blood Glucose
At 16 wks of age, there was no difference in systolic blood
pressure between groups (Table 1). Diabetic db/db mice displayed
significantly higher blood glucose concentrations and body weight
compared to Db/db mice (Table 1).
Mesenteric Resistance Artery Structure in 16 wk-old Mice
MRAs from 16 wk-old db/db mice had larger internal lumen
diameter and external diameter measured at each pressure
compared to MRAs isolated from control mice (Fig. 1a,b). Media
cross-sectional area was also significantly increased in db/db mice
compared to control mice (Fig. 1c); however, wall thickness was
not different between groups (data not shown). As a result, the
wall-to-lumen ratio was significantly decreased in db/db com-
pared to control mice (Fig. 1d).
MRAs from db/db mice were more compliant at low pressures
than control mice (Fig. 2a). Neither the diabetic nor control
Figure 2. Compliance (45.1±12.7 vs 118.9±11.9 mm
2/mmHg at 75 mmHg, p,0.001) was increased in db/db MRAs while cross-
sectional distensibility (0.009±0.002 vs 0.010±0.0 kPa at 75 mmHg, NS) was unchanged when compared to Db/db mice under
physiological pressures. The db/db stress-strain curve was shifted to the right of the Db/db MRA stress-strain curve, while incremental elastic
modulus was mostly unchanged over a range of pressures, although an increase was observed at 125 mmHg: a. cross-sectional compliance, b. cross-
sectional distensibility, c. stress-strain relationship, d. incremental elastic modulus. Two-way ANOVA: Db/db vs db/db,*** p,0.001, means 6 SEM;
n=8 for each group.
doi:10.1371/journal.pone.0023337.g002
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of MMP-9, MMP-12 and GAPDH expression. b. Quantification of MMP-9, MMP-12 and GAPDH protein levels in Db/db and db/db mice. Unpaired t-test:
Db/db vs db/db, *p,0.05, **p,0.005, means 6 SEM; n=3 tissue lysates pooled from 12 mice for each group.
doi:10.1371/journal.pone.0023337.g003
Figure 4. Increased vascular expression of and PAI-1, TIMP-1 and TIMP-2 in MRAs from diabetic db/db mice. a. Representative
immunoblot of PAI-1 and GAPDH expression. b. Quantification of PAI-1 protein levels in Db/db and db/db mice. c. Representative immunoblot of
TIMP-1, TIMP-2 and GAPDH expression. d. Quantification of TIMP-1, TIMP-2 and GAPDH protein levels in Db/db and db/db mice. Unpaired t-test:
Db/db vs db/db, * p,0.05, *** p,0.001, means 6 SEM; n=3 tissue lysates pooled from 12 mice for each group.
doi:10.1371/journal.pone.0023337.g004
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sectional distensibility, except for a minor increase at 25 mmHg
of pressure (Fig. 2b). Circumferential wall stress was significantly
greater in db/db mesenteric arteries compared with control
arteries at 75, 100, and 125 mmHg (data not shown). Finally,
there was a rightward shift in the stress-strain relationship in
db/db MRAs compared to control (Fig. 2c). Incremental elastic
modulus, calculated from the incremental slopes of the stress-strain
curve, was generally not different between normal and diabetic
MRAs, although the diabetic MRAs were stiffer at the highest
pressure (125 mmHg, Fig. 2d).
Expression of Matrix Regulatory Proteins in Mesenteric
Resistance Arteries in 16 wk-old Mice
Western blot analysis was used to determine the relationship
between pro- and anti-fibrotic regulatory protein expression and
ECM accumulation. MMP-9 and MMP-12 protein expression
were significantly increased in MRAs isolated from diabetic db/db
mice compared with the controls (Fig. 3a,b,c).
The expression of PAI-1 (Fig. 4a,b), and TIMP-1 and TIMP-2
(Fig. 4c,d,e), were significantly increased in db/db MRAs
compared with control vessels. PSR staining indicated that these
dynamic changes in pro- and anti-fibrotic protein expression did
not result in a net change in collagen accumulation in db/db
MRAs within the vascular wall (Fig. 5a,b).
MRA remodeling and Superior Mesenteric Blood Flow in
12 wk-old Mice
We next determined whether changes in superior mesenteric
blood flow preceded the observed hypertrophic outward remod-
eling in 16 wk-old db/db mice. At 12 wks of age, there was no
observed MRA structural remodeling in db/db mice as evidenced
by no differences in lumen diameter, external diameter, medial
cross-sectional area, and wall:lumen ratio (Fig. 6a-d). MRA
mechanics between normal and diabetic mice were also
unchanged (data not shown). Conversely, superior mesenteric
blood flow in db/db mice was significantly increased by 46% when
compared with control mice (Fig. 7).
Figure 5. Vascular wall collagen content was unchanged in Db/db and db/db mice. a. Representative MRAs from Db/db and db/db mice
stained with picrosirius red under both bright field and polarized light. b. Quantification of vascular wall collagen and normalized to wall cross-
sectional area. Unpaired t-test: Db/db vs db/db, NS, means 6 SEM; n=8 for each group. Scale bars=40 mm.
doi:10.1371/journal.pone.0023337.g005
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This study shows for the first time that MRAs in 16 wk-old type
2 DM db/db mice undergo hypertrophic outward remodeling
associated with increased compliance at lower pressures and
augmented stiffness at higher pressures. This remodeling process
was accompanied by dynamic changes in the expression of MMP-
9 and MMP-12, TIMP-1 and TIMP-2, and PAI-1 but no net
change in medial collagen. These structural and biochemical
findings were preceded by a 46% increase in superior mesenteric
artery blood flow in 12 wk-old diabetic mice – a time point at
which no MRA remodeling was present – suggesting that
increased hemodynamic forces may precede and chronically
influence downstream resistance artery remodeling.
Structural alterations of small arterial walls are the most potent
predictors of adverse cardiovascular events in high-risk populations,
including type 2 diabetic patients [23]. Arterial wall hypertrophy is
present in resistance arteries (from gluteal biopsies) from patients
with type 2 DM, with little to no change in intraluminal diameter
[24]. Other studies in MRAs from streptozotocin-treated rats
demonstrated either vascular hypertrophy [25] or eutrophic (i.e. no
change in medial cross sectional area) outward remodeling as little
as 3 weeks after experimentally-induced DM [26]. In contrast, our
data reveal that MRAs in type 2 DM db/db mice had increased
luminal and external diameters and medial cross-sectional areas,
indicating hypertrophic outward remodeling. These structural
changes were blood pressure-independent since we saw no
significant differences in systolic blood pressure between groups
(Table 1).
The reasons for these disparate remodeling processes are
unclear but may reflect differences in vascular beds, insulin
sensitivity, obesity and/or chronic exposure to hyperglycemia.
Previous studies have shown that chronic changes in blood flow
are one of the major stimuli dictating arterial diameter and
reorganization of the vascular wall [27]. One possible explanation
for our observations is that flow-induced hemodynamic changes
may supersede the local neurohormonal and metabolic milieu that
favor inward remodeling. Chronic hyperphagia in this model
causes increased blood flow to accommodate increased nutrient
uptake [28]. The thickness, composition and architecture of the
artery wall are determined in part by stresses imposed by pressure
and flow [29]. Both chronic increases in blood flow and wall stress
Figure 6. Lumen diameter (119.7±10.3 vs 147.8±9.2 mm at 75 mmHg, p.0.05), external diameter (133.7±9.7 vs 161.3±9.3 mma t
75 mmHg, p.0.05), media cross-sectional area (2736.3±224.1 vs 3289.1±360.1 mm
2 at 75 mmHg, p.0.05), and wall:lumen ratio
(6.2±1.0 vs 4.6±0.5 at 75 mmHg, p.0.05) of 12 wk-old diabetic MRAs were unchanged when compared to Db/db mice over a
range of pressures: a. Lumen diameter, b. external diameter, c. medial cross-sectional area, d. wall:lumen ratio. Two-way ANOVA:
Db/db vs db/db, NS, means 6 SEM; n=6 for each group.
doi:10.1371/journal.pone.0023337.g006
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remodeling [18]. As shown by us and others, blood flow to the
small intestine is also increased in the diabetic animals secondary
to prolonged hyperphagia and may act as a stimulus for outward
remodeling [30]. This is consistent with data showing outward
hypertrophic remodeling of resistance arteries is the result of a
chronic increase in blood flow [18,31,32,33]. Our data support the
notion that increased blood flow resulting from prolonged feeding
in obese db/db mice outweigh the influences of hyperglycemia,
inflammation, and oxidative stress that dictate vessel wall
remodeling in DM. Given that each vascular bed is exposed to a
unique pattern of hemodynamic, neurohormonal and inflamma-
tory stimuli, the effects of type 2 DM on vascular remodeling
cannot be globally applied to all resistance beds.
Vessel wall remodeling also leads to changes in the structural
mechanical properties. Arterial compliance, defined as the change
in lumen area for a given change in pressure, depends on the size
of the vascular lumen as a hollow structure and cushions changes
in arterial pulse pressure. Distensibility represents compliance
corrected for vascular lumen size and depends on the medial mass
and intrinsic elastic properties of the vascular wall [26,34]. Einc
reflects the mechanical properties of the vascular wall material
(collagen, vascular smooth muscle, elastin and other ECM
components) independent of geometry. Our results show increased
MRA cross-sectional compliance in db/db mice, resulting in a less
stiff vessel at lower physiological pressures. Conversely, there were
no differences in cross-sectional distensibility between normal and
diabetic mice, except for an increase at 25 mmHg. These data are
consistent with previous reports that increased arterial compliance
fails to correlate with an increase in arterial distensibility [26,34],
which are likely due to the combination of increased lumen
diameter and wall stress without alterations in wall thickness. The
stress–strain relationship is an additional geometry-dependent
measure of vascular compliance. In general, leftward deviations in
this parameter functionally describe a stiffer, less compliant vessel
[35]. In contrast, our results show a rightward deviation in the
stress-strain curve in diabetic MRAs, indicating a less stiff, more
compliant vessel compared to non-diabetic controls in the face of
an unchanged incremental modulus, except for a transient
increase at higher physiological pressure. These data are the first
to report increased MRA cross-sectional compliance in type 2 DM
mice, since most studies have reported either a leftward shift or no
differences in the stress-strain relationship [36,37]. The current
study also demonstrates that as intraluminal pressure increases,
wall stress increases in diabetic mice compared to controls, which
is a function of and directly proportional to increased luminal
diameter. Previous studies have shown that changes in wall stress
result in either impaired myogenic response (stimulus for vascular
hypertrophy) or in altered vessel geometry to reduce wall stress
[14,18,24,38,39].
The molecular mechanisms that govern ECM remodeling in
diabetic resistance arteries have not been extensively studied. Here
we show that type 2 DM MRA structural remodeling was
accompanied by no net matrix accumulation. This was not
surprising, since matrix accumulation is usually associated with
vessel stiffness and inward remodeling [40]. However, the
concomitant increase in both anti-fibrotic (MMP-9 and MMP-
12) and pro-fibrotic (TIMP-1, TIMP-2 and PAI-1) molecules is
indicative of dynamic ECM turnover. We speculate that the ECM
is in a constant state of flux as the vessel undergoes outward
Figure 7. Superior mesenteric blood flow was increased in 12 wk-old diabetic db/db mice (Db/db 3.02±0.27 vs db/db 4.42±0.27 ml min
21;
p,0.05). a. Representative tracings from actual blood flow recordings. b. Quantification of SMA blood flow. Unpaired t-test: Db/db vs db/db,
*p ,0.05, means 6 SEM; n=5 for Db/db and n=6 for db/db.
doi:10.1371/journal.pone.0023337.g007
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mechanisms involved in the induction of matrix regulatory
proteins are unclear but may reflect both hemodynamic and
humoral responses. Increased MMP-9 and MMP-12, which can
hydrolyze elastin, may be secondary to reactive oxidative species
and inflammation in diabetic vessels. Uemura et al. demonstrated
an increase in MMP-9 activity, mRNA and protein expression in
endothelial cells exposed to hyperglycemia, which may facilitate
the pro-inflammatory response in the vessel wall [41]. On the
other hand, the increased expression of pro-fibrotic factors, such as
PAI-1 and ECM accumulation is consistent with DM-induced
nephropathy and vasculopathy [17,42]. Similarly, other groups
report an imbalance between MMP and TIMP levels that lead to
increased synthesis and accumulation of matrix proteins in the
heart and kidneys of experimental models of DM [15,16]. Plasma
and urine samples from human diabetic patients show marked
increases in MMP and TIMP concentrations, reflecting abnormal
ECM turnover [43,44]. It is also important to note that it is the
overall organization of the ECM into a 3-dimensional network, as
well as the fluid properties of the non-collagenous components of
the ECM (elastin, fibrin) that will ultimately impart elasticity and
compliance to the tissue [45]. Thus the overall balance between
anti-fibrotic and pro-fibrotic factors at this time point maintains
ECM integrity without accumulation in an attempt limit outward
vessel remodeling. Future studies examining the temporal and
spatial profile of MMPs and TIMPs in DM-induced microvascular
remodeling are warranted.
In summary, our study shows significant hypertrophic outward
remodeling of MRAs from obese, type 2 diabetic db/db mice that
is accompanied by increased compliance and wall stress. This
remodeling likely reflects an integrated response of a combination
of increased regional hemodynamics that precedes structural
adaptation, type 2 DM-dependent insulin resistance, inflamma-
tion, obesity, and oxidative stress. Changes in the balance between
pro- and anti-fibrotic factors resulted in no net ECM accumulation
that work in concert to reduce wall stress and limit outward
remodeling.
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